Increase/Decrease in Cash: The total change in cash for the company over the given period.
IMMURON (IMRN) had Increase/Decrease in Cash of $4.70M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$9.80M |
|
$0.14M |
|
$0.14M |
|
$9.94M |
|
$1.22M |
|
-- |
|
$0.13M |
|
$1.35M |
|
$8.58M |
|
$8.58M |
|
$8.58M |
|
8.17M |
|
| Cash Flow Statement Financials | |
$-1.68M |
|
$2.05M |
|
$4.41M |
|
$1.86M |
|
$6.56M |
|
|
Increase/Decrease in Cash |
$4.70M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|